Literature DB >> 17130744

Meal patterns, dietary fat intake and pancreatic enzyme use in preadolescent children with cystic fibrosis.

Joan I Schall1, Tyrone Bentley, Virginia A Stallings.   

Abstract

OBJECTIVES: To describe the usual pattern of intake and adherence to cystic fibrosis (CF) food and pancreatic enzyme replacement therapy (PERT) recommendations in preadolescent children with CF and pancreatic insufficiency (PI).
METHODS: Children, 8 to 11 years old, with CF and PI were assessed for PERT adherence ratio (number taken/number prescribed per day) and energy and fat intake for 7 days (weighed food records), adherence to PERT and dietary recommendations, pulmonary function, growth status and stool fat malabsorption. Using the PERT adherence ratio, children were divided into good (> or =80%), moderate (60% to 79%) and poor (<60%) adherence groups.
RESULTS: Of the 75 children (age, 9.3 +/- 1.0 years; forced expiratory volume in 1 s, 95 +/- 14% predicted), 61% consumed less than 120% of energy intake, and 72% consumed less than 40% of calories as fat recommended for CF. Using the PERT adherence ratio (mean +/- SD, 75 +/- 14%), 29%, 61% and 9% of children had good, moderate and poor adherence, respectively. Better adherence to PERT was significantly associated with missing fewer snacks, higher energy intake, greater fat content of snacks and poorer growth status. About 85% of the children were in the 500 to 4000 lipase unit (LU) of PERT (LU/g fat per day) and 500 to 2500 LU/kg per body weight per meal guidelines, whereas only 58% to 68% were within the guidelines for snacks. Eleven percent of children always took PERT at an inappropriate time after meals.
CONCLUSIONS: Most preadolescent children with CF and PI did not meet dietary recommendations. Future educational and behavioral interventions focused on increasing PERT adherence with snacks, fat content of meals and snacks, appropriate timing of enzymes and adjustment of PERT and meal fat content are suggested.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130744     DOI: 10.1097/01.mpg.0000234082.47884.d9

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Adherence and psychopathology in children and adolescents with cystic fibrosis.

Authors:  Tonya White; Judith Miller; Gail L Smith; William M McMahon
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-09-20       Impact factor: 4.785

2.  Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency.

Authors:  Maria R Mascarenhas; John Mondick; Jeffrey S Barrett; Martha Wilson; Virginia A Stallings; Joan I Schall
Journal:  J Clin Pharmacol       Date:  2015-03-23       Impact factor: 3.126

3.  Psychological predictors of nutritional adherence in adolescents with cystic fibrosis.

Authors:  Adrienne P Borschuk; Stephanie S Filigno; Lisa Opipari-Arrigan; James Peugh; Lori J Stark
Journal:  Clin Nutr ESPEN       Date:  2019-06-19

4.  Parental Depression and Pancreatic Enzymes Adherence in Children With Cystic Fibrosis.

Authors:  David H Barker; Alexandra L Quittner
Journal:  Pediatrics       Date:  2016-01-05       Impact factor: 7.124

5.  In Vitro Digestion of Lipids in Real Foods: Influence of Lipid Organization Within the Food Matrix and Interactions with Nonlipid Components.

Authors:  Joaquim Calvo-Lerma; Victoria Fornés-Ferrer; Ana Heredia; Ana Andrés
Journal:  J Food Sci       Date:  2018-09-14       Impact factor: 3.167

6.  Clinical validation of an evidence-based method to adjust Pancreatic Enzyme Replacement Therapy through a prospective interventional study in paediatric patients with Cystic Fibrosis.

Authors:  Joaquim Calvo-Lerma; Jessie Hulst; Mieke Boon; Carla Colombo; Etna Masip; Mar Ruperto; Victoria Fornés-Ferrer; Els van der Wiel; Ine Claes; Maria Garriga; Maria Roca; Paula Crespo-Escobar; Anna Bulfamante; Sandra Woodcock; Sandra Martínez-Barona; Ana Andrés; Kris de Boeck; Carmen Ribes-Koninckx
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

7.  A first approach for an evidence-based in vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis.

Authors:  Joaquim Calvo-Lerma; Victoria Fornés-Ferrer; Irene Peinado; Ana Heredia; Carmen Ribes-Koninckx; Ana Andrés
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.